SFVAX Fees and Costs — AIG Strategic Value Fund, Class A
Data updated: 2021-06-29
The net expense ratio is 1.50%: a 0.75% management fee, a 0.35% 12b-1 fee plus 0.40% other expenses. This share class carries a maximum front-end sales load of 5.75%. In fiscal 2020 the fund paid $76K in broker commissions, 0.0440% of average net assets, and portfolio turnover was 47%.
SFVAX Fees and Expenses
Annual operating expenses and sales charges of SFVAX. Prospectus, as of February 28, 2021.
| Annual operating expenses | |
|---|---|
| Management fee | 0.75% |
| 12b-1 fee | 0.35% |
| Other expenses | 0.40% |
| Gross expense ratio | 1.50% |
| Fee waiver | — |
| Net expense ratio | 1.50% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
SFVAX Costs Over Time
On $10,000 invested in SFVAX, assuming 5% a year before costs, total costs come to $1,634 over 5 years, cutting the return by 2.84% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $575 | $575 | $575 |
| Fund expenses (net expense ratio 1.50%) | $148 | $461 | $794 |
| Trading costs (broker commissions) | $4 | $14 | $23 |
| Lost growth on money paid in costs | $29 | $114 | $242 |
| Total costs | $757 | $1,163 | $1,634 |
| Value after costs | $9,743 | $10,413 | $11,129 |
| Impact on return, per year | 7.57% | 3.64% | 2.84% |
SFVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2020.
- Explicit cost rate (commissions ÷ average net assets): 0.0440%
- Total broker commissions: $76K
- Bought from dealers (principal trades, not a cost): $301.8M
- Portfolio turnover (prospectus): 47%
- Securities lending: none during the year
SFVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Nomura Securities International, Inc. | $65K | 85.22% |
| Stifel, Nicolaus & Company, Incorporated | $7K | 8.88% |
| Oppenheimer & Co. Inc. | $2K | 2.42% |
| Virtu Itg LLC | $1K | 1.79% |
| BofA Securities, Inc. | $625 | 0.82% |
| National Financial Services LLC | $590 | 0.77% |
| UBS Securities LLC | $72 | 0.09% |
SFVAX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| State Street Bank and Trust Company | $301.8M | 100.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.